Bipartisan House members questioned pharmaceutical industry leaders on Feb. 11, seeking to learn how the complicated drug supply chain may increase the cost of prescription medications.
“One of the most frustrating aspects of the supply chain is that it operates as if in a black box,” Rep. Morgan Griffith (R-Va.) said in opening the hearing by the Health Subcommittee of the House Energy and Commerce Committee.
